
Performance of a True Point-of-Care Assay for HIV-1/2 Viral Load Measurement at Antenatal and Postpartum Services
Author(s) -
Bindiya Meggi,
Timothy Bollinger,
Alcina Zitha,
Chishamiso Mudenyanga,
Adolfo Vúbil,
Dadirayi Mutsaka,
Carihachigule,
Nédio Mabunda,
Osvaldo Loquiha,
Arne Kroidl,
Ilesh Jani
Publication year - 2021
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000002621
Subject(s) - medicine , viral load , point of care testing , point of care , referral , venous blood , obstetrics , postpartum period , human immunodeficiency virus (hiv) , confidence interval , antiretroviral therapy , pregnancy , immunology , family medicine , nursing , biology , genetics
Timely viral load (VL) results during pregnancy and the postpartum period are crucial for HIV disease management and for preventing mother-to-child transmission. Point-of-care (POC) VL testing could reduce turnaround times and streamline patient management. We evaluated the diagnostic performance of the novel m-PIMA HIV-1/2 VL assay (Abbott, Chicago, IL) in Mozambique.